European Academy of Allergy and Clinical Immunology

Last updated
European Academy of Allergy and Clinical Immunology
AbbreviationEAACI
Formation1956
TypeMedical professional academy (non-profit)
LocationZurich, Switzerland
Region servedEurope
MembershipAllergists, Immunologists
PresidentStefano Del Giacco, Italy
Websitewww.eaaci.org

The European Academy of Allergy and Clinical Immunology (EAACI) is a non-profit organisation for European clinicians, researchers and allied health professionals in the field of allergy and clinical immunology, covering asthma, rhinitis, eczema and occupational allergy, food and drug allergy, severe anaphylactic reactions, autoimmune disorders, and immunodeficiencies.

Contents

More than 50 national allergy societies are members, representing more than 15,000 people from 124 countries.[ citation needed ]

History

EAACI was founded in 1956 in Florence, Italy; the following year, its constitution and by-laws were codified in Utrecht, The Netherlands. [1]

Conferences and training courses

The EAACI organises a four-day annual congress, usually attended by around 7000–8000 international participants. [2] The 2023 congress was held in Hamburg, Hamburg. [3] The association also organises smaller three-day meetings addressing specific areas in the field of allergy, [4] which are usually attended by 250–1500 participants. [5] The association offers training courses on specific topics. [4]

Affiliations

Sponsors

EAACI is sponsored by pharmaceutical and medical technology companies including AstraZeneca, DBV Technologies, GlaxoSmithKline, HAL Allergy Group, Novartis, Regeneron Pharmaceuticals, Sanofi, Stallergenes Greer, and Thermo Fisher Scientific. [6]

Partnerships

EAACI is a member of the Alliance for Biomedical Research in Europe (BioMed Alliance) and, European Chronic Disease Alliance (ECDA), and became involved in the activities of the European Medicines Agency in April 2014. [7]

Publications and resources

The EAACI publishes three peer-reviewed academic journals:

It also publishes other resources including guidelines and books. [4]

Related Research Articles

A radioallergosorbent test (RAST) is a blood test using radioimmunoassay test to detect specific IgE antibodies in order to determine the substances a subject is allergic to. This is different from a skin allergy test, which determines allergy by the reaction of a person's skin to different substances.

The National Institute of Allergy and Infectious Diseases is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

<span class="mw-page-title-main">Allergen immunotherapy</span> Medical treatment for environmental allergies

Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for environmental allergies, such as insect bites, and asthma. Immunotherapy involves exposing people to larger and larger amounts of allergens in an attempt to change the immune system's response.

Translational medicine develops the clinical practice applications of the basic science aspects of the biomedical sciences; that is, it translates basic science to applied science in medical practice. It is defined by the European Society for Translational Medicine as "an interdisciplinary branch of the biomedical field supported by three main pillars: benchside, bedside, and community". The goal of translational medicine is to combine disciplines, resources, expertise, and techniques within these pillars to promote enhancements in prevention, diagnosis, and therapies. Accordingly, translational medicine is a highly interdisciplinary field, the primary goal of which is to coalesce assets of various natures within the individual pillars in order to improve the global healthcare system significantly.

ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy (AIT) products for the prevention and treatment of allergy. It is one of the world's largest makers of allergy immunotherapy products with 67% of its revenue coming from sales in Europe.

<span class="mw-page-title-main">European Society of Cardiology</span> Non-profit professional association

The European Society of Cardiology (ESC) is an independent non-profit, non-governmental professional association that works to advance the prevention, diagnosis and management of diseases of the heart and blood vessels, and improve scientific understanding of the heart and vascular system. This is done by:

Allied Academies is a reportedly fraudulent corporation chartered under the laws of North Carolina. Its postal address is in London, United Kingdom. It presents itself as an association of scholars, with supporting and encouraging research and the sharing and exchange of knowledge as its stated aims. The organization consists of 30 affiliate academies, which provide awards to academics and publish academic journals both online and in hard copy for members. Since 2015 the organization has been listed on Jeffrey Beall's list of "potential, possible, or probable predatory scholarly open-access publishers". It is in a partnership with OMICS Publishing Group which uses its website and logo. In 2018, OMICS owner Srinubabu Gedela declared that he had informed the Nevada court that Allied Academies was a subsidiary of OMICS International. During a conference in 2018, they falsely listed a prominent chemist among its organizing committee who had not agreed to this and was not affiliated with Allied Academies.

<span class="mw-page-title-main">Margaret Hamburg</span> American public health administrator (born 1955)

Margaret Ann "Peggy" Hamburg is an American physician and public health administrator, who is serving as the chair of the board of the American Association for the Advancement of Science (AAAS) and co-chair of the InterAcademy Partnership (IAP). She served as the 21st Commissioner of the U.S. Food and Drug Administration from May 2009 to April 2015.

<i>Allergy</i> (journal) Academic journal

Allergy is a monthly peer-reviewed medical journal covering the field of allergy and immunology, that is published by Wiley on behalf of the European Academy of Allergology and Clinical Immunology. It publishes both original articles and reviews. The editor-in-chief is Cezmi Akdis. According to the Journal Citation Reports, the journal has a 2022 impact factor of 12.4.

<span class="mw-page-title-main">World Allergy Organization</span>

The World Allergy Organization (WAO) is an international umbrella organization of 108 regional and national allergology and clinical immunology societies. Since the first World Allergy Congress (WAC) held in Zurich, Switzerland in 1951, there have been 28 WACs as well as a number of WAO International Science Conferences (WISC), Webinars, and Symposia. Beyond sharing research findings, these meetings also allocate funds for postgraduate programs on allergy and clinical immunology.

Igor Petrovych Kaidashev is a Ukrainian immunologist and allergist, MD, and Professor. Igor Kaidashev is President of the Ukrainian Society of Immunology, Allergy and Immunorehabilitation, Professor of the Department of Internal Medicine No. 3 with Phthisiology, and Vice-Rector for Research & Development at Poltava State Medical University (PSMU) since 2010.

<span class="mw-page-title-main">Kari Nadeau</span> American Physician and scientist

Kari C. Nadeau is the Chair of the Department of Environmental Health at Harvard School of Public Health and John Rock Professor of Climate and Population Studies. She is adjunct professor at Stanford University in the Department of Pediatrics and the co-chair of the Medical Societies Consortium for Climate Change and Health. She practices Allergy, Asthma, Immunology in children and adults. She has published over 400+ papers, many in the field of climate change and health. Her team focuses on quantifying health outcomes of solutions as they pertain climate change mitigation and adaptation at the local, regional, country, and global levels. Dr. Nadeau, with a team of individuals and patients and families, has been able to help major progress and impact in the clinical fields of immunology, infection, asthma, and allergy. Dr. Nadeau is a member of the National Academy of Medicine and the U.S. EPA Children’s Health Protection Committee.

<span class="mw-page-title-main">HAL Allergy Group</span>

HAL Allergy Group is a pharmaceutical company that develops, produces and sells products for allergy diagnostic and allergen immunotherapy (AIT). The research facilities and headquarters are located at the Leiden Bio Science Park, Netherlands.

Pediatric Allergy and Immunology is a peer-reviewed medical journal covering immunology and allergy as they relate to pediatrics. It was established in 1990 and is published eight times per year by John Wiley & Sons. It is the official journal of the European Academy of Allergy and Clinical Immunology. The editor-in-chief is Philippe Eigenmann. According to the Journal Citation Reports, the journal has a 2020 impact factor of 6.377, ranking it 6th out of 28 journals in the category "Allergy".

Erika von Mutius is a German pediatrician and allergologist at the Helmholtz Center Munich and the Ludwig-Maximilians-University of Munich. Her research interests include paediatrics, pediatric pneumology, allergology and epidemiology.

Cezmi Akdis is a medical researcher in the field of immunology. He is director of the Swiss Institute of Allergy and Asthma Research (SIAF) in Davos, Switzerland and the editor in chief of the journal Allergy.

Marc E. Rothenberg is an American physician-scientist who has made significant contributions to the fields of allergy, gastroenterology, and immunology. He is currently a Professor of Pediatrics, at Cincinnati Children's Hospital Medical Center, and the University of Cincinnati College of Medicine, the Director of the Division of Allergy and Immunology, the Director of the Cincinnati Center for Eosinophilic Disorders, and the principal investigator of the Consortium of Eosinophilic Disease Researchers (CEGIR) as part of the Rare Disease Clinical Research Network of the National Institute of Health. Rothenberg's research is focused on eosinophilic gastrointestinal diseases.

<span class="mw-page-title-main">Giorgio Walter Canonica</span> Italian allergist and pulmonologist

Giorgio Walter Canonica is an Italian allergist, pulmonologist and professor of Respiratory Medicine at Humanitas University, Milan, Italy and Director Personalized Medicine Asthma & Allergy Center at Humanitas Research Hospital IRCCS-Milano Italy since December 2016. He is known for his research work related to innovative treatment strategies for allergic diseases which includes biological response modifier in form of targeted immunotherapy with primary emphasis on sublingual immunotherapy (SLIT). He has served as Secretary General and President elect of World Allergy Organisation for six consecutive years and has served as president of the same organization during 2007–09. He is also the vice-president of INTERASMA.

Bernadette Eberlein is a dermatologist, allergologist, academic, and researcher. She is the Senior Physician of the private outpatient clinic, the Photodermatology unit, the unit for Soft X-Ray Therapy at Technical University of Munich.

Mimi Tang is an Australian immunologist allergist specialized in food oral immunotherapy, such as pairing exposure to peanut proteins with probiotics.

References

  1. Umberto Serafini (May 1975), History (PDF), EAACI
  2. "Annual Congress". EAACI Knowledge Hub. Retrieved 2023-05-10.
  3. "Review of the European Academy of Allergy and Clinical Immunology (EAACI) Congress", Allergy & Immunology, EMJ, 18 July 2019, retrieved 3 January 2020
  4. 1 2 3 "EAACI - Annual Congress". EAACI. Retrieved 2023-05-10.
  5. "EAACI - Focused Meetings". EAACI. Retrieved 2023-05-10.
  6. "Founder Sponsors". European Academy of Allergy and Clinical Immunology. 2022-06-08. Archived from the original on 2022-06-11. Retrieved 2022-06-11.{{cite web}}: CS1 maint: bot: original URL status unknown (link)
  7. "Partnerships". European Academy of Allergy and Clinical Immunology. 2022-04-04. Archived from the original on 2022-06-11. Retrieved 2022-06-11.
  8. "Allergy". Wiley Online Library.
  9. "Pediatric Allergy and Immunology". Wiley Online Library.
  10. "Clinical and Translational Allergy". BioMed Central.